Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: PROTOKINETIX, INCORPORATED
CIK: 1128189
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2011-08-15
Last Filing Date: 2025-03-28
SEC Filings
Start End Frame Filed ACCN Value View
2015-01-01 2015-03-31 CY2014Q1 2015-05-20 0001079973-15-000396 $ 182,277,544 View
2015-04-01 2015-06-30 CY2014Q2 2015-08-14 0001079973-15-000541 $ 199,308,477 View
2015-07-01 2015-09-30 CY2014Q3 2015-11-16 0001079973-15-000654 $ 202,076,618 View
2015-01-01 2015-12-31 CY2014 2016-03-30 0001079973-16-000885 $ 197,978,111 View
2016-01-01 2016-03-31 CY2015Q1 2016-05-16 0001079973-16-000974 $ 216,635,400 View
2016-04-01 2016-06-30 CY2015Q2 2016-08-15 0001079973-16-001125 $ 217,340,895 View
2016-07-01 2016-09-30 CY2015Q3 2016-11-14 0001079973-16-001279 $ 222,088,754 View
2016-01-01 2016-12-31 CY2015 2017-02-21 0001079973-17-000127 $ 211,613,392 View
2017-01-01 2017-03-31 CY2016Q1 2017-05-12 0001079973-17-000280 $ 226,457,836 View
2017-04-01 2017-06-30 CY2016Q2 2017-08-08 0001079973-17-000456 $ 245,952,433 View
2017-07-01 2017-09-30 CY2016Q3 2017-11-13 0001079973-17-000662 $ 247,148,085 View
2017-01-01 2017-12-31 CY2016 2018-03-09 0001079973-18-000141 $ 246,598,460 View
2018-01-01 2018-03-31 CY2017Q1 2018-04-26 0001079973-18-000278 $ 254,263,774 View
2018-04-01 2018-06-30 CY2017Q2 2018-07-24 0001079973-18-000430 $ 254,909,923 View
2019-01-01 2019-12-31 CY2018 2020-02-19 0001079973-20-000119 $ 268,984,776 View
2020-01-01 2020-12-31 CY2019 2021-03-05 0001079973-21-000148 $ 278,598,615 View
2021-01-01 2021-03-31 CY2021Q1 2021-04-16 0001079973-21-000288 $ 281,390,520 View
2021-04-01 2021-06-30 CY2021Q2 2021-07-28 0001079973-21-000666 $ 290,414,046 View
2021-07-01 2021-09-30 CY2021Q3 2021-11-12 0001079973-21-001122 $ 293,201,373 View
2021-01-01 2021-12-31 CY2021 2022-03-10 0001079973-22-000230 $ 4,795,429 View
2011-04-01 2011-06-30 CY2010Q2 2011-08-15 0001062993-11-003261 $ 93,594,851 View
2011-07-01 2011-09-30 CY2010Q3 2011-11-14 0001062993-11-004468 $ 94,424,390 View
2011-01-01 2011-12-31 CY2010 2012-03-20 0001062993-12-000931 $ 93,592,433 View
2012-01-01 2012-12-31 CY2011 2014-04-30 0001062993-14-002480 $ 129,224,762 View
2013-01-01 2013-12-31 CY2012 2014-05-27 0001062993-14-003397 $ 137,107,228 View
2014-01-01 2014-03-31 CY2013Q1 2014-06-05 0001062993-14-003562 $ 166,446,322 View
2014-04-01 2014-06-30 CY2013Q2 2014-08-14 0001062993-14-004929 $ 171,697,598 View
2014-07-01 2014-09-30 CY2013Q3 2014-11-14 0001062993-14-006669 $ 175,662,433 View
2014-01-01 2014-12-31 CY2013 2015-04-14 0001079973-15-000278 $ 172,401,474 View
2018-07-01 2018-09-30 CY2017Q3 2018-10-26 0001079973-18-000589 $ 257,952,433 View
2019-01-01 2019-03-31 CY2018Q1 2019-05-07 0001079973-19-000274 $ 260,280,210 View
2019-04-01 2019-06-30 CY2018Q2 2019-07-26 0001079973-19-000422 $ 268,477,891 View
2019-07-01 2019-09-30 CY2018Q3 2019-10-28 0001079973-19-000540 $ 272,816,256 View
2020-01-01 2020-03-31 CY2019Q1 2020-04-27 0001079973-20-000310 $ 275,400,259 View
2020-04-01 2020-06-30 CY2019Q2 2020-07-10 0001079973-20-000583 $ 276,557,768 View
2020-07-01 2020-09-30 CY2019Q3 2020-10-16 0001079973-20-000888 $ 279,648,342 View
2022-01-01 2022-09-30 CY2022Q3I 2022-10-31 0001079973-22-001380 $ -1,323,652 View
2023-07-01 2023-09-30 CY2022Q3 2023-10-18 0001079973-23-001455 $ 335,630,151 View
2024-01-01 2024-03-31 CY2024Q1 2024-05-15 0001079973-24-000714 $ 333,102,754 View
2024-04-01 2024-06-30 CY2024Q2 2024-07-30 0001079973-24-001123 $ 353,972,460 View
2024-07-01 2024-09-30 CY2024Q3 2024-11-12 0001079973-24-001493 $ 364,849,717 View
2023-01-01 2023-12-31 CY2022 2024-03-20 0001079973-24-000403 $ 179,000 View
2012-01-01 2012-03-31 CY2011Q1 2012-05-15 0001062993-12-001807 $ 119,512,433 View
2012-04-01 2012-06-30 CY2011Q2 2012-08-20 0001062993-12-003121 $ 121,937,091 View
2012-07-01 2012-09-30 CY2011Q3 2012-11-15 0001062993-12-004918 $ 132,369,597 View
2013-01-01 2013-03-31 CY2012Q1 2014-05-14 0001062993-14-002919 $ 134,514,433 View
2013-04-01 2013-06-30 CY2012Q2 2014-05-14 0001062993-14-002931 $ 135,703,642 View
2013-07-01 2013-09-30 CY2012Q3 2014-05-15 0001062993-14-002950 $ 137,948,303 View
2018-01-01 2018-12-31 CY2017 2019-03-12 0001079973-19-000124 $ 256,217,173 View
2022-01-01 2022-03-31 CY2021Q1I 2022-05-10 0001079973-22-000560 $ 58,879 View
2022-01-01 2022-06-30 CY2022Q2I 2022-07-29 0001079973-22-000911 $ 0 View
2022-01-01 2022-12-31 CY2021 2023-03-17 0001079973-23-000353 $ -1,907,309 View
2023-01-01 2023-03-31 CY2022Q1 2023-05-02 0001079973-23-000595 $ -107,038 View
2023-04-01 2023-06-30 CY2022Q2 2023-07-14 0001079973-23-000958 $ 335,630,151 View
2024-01-01 2024-12-31 CY2024 2025-03-28 0001079973-25-000516 $ 5,700,000 View
SEC Facts By Type
Type Name Description View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Cash and Cash Equivalents, Fair Value Disclosure Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, Domestic Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. View
us-gaap Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Long-term Line of Credit The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. View
us-gaap Proceeds from Deposits on Real Estate Sales Cash inflow related to amounts received in advance from a potential buyer showing or confirming an intention to complete an acquisition of land, buildings, other structures, or any item classified as real estate. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). View
us-gaap Temporary Equity, Share Subscriptions The number of securities classified as temporary equity that have been allocated to investors to buy. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Stock Issued During Period, Shares, Other Number of shares of stock issued attributable to transactions classified as other. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Accounts Payable and Other Accrued Liabilities Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. View
us-gaap Accretion Expense Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations. View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Amortization The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. View
us-gaap Advances to Affiliate Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Share-based Payment Arrangement, Expense, after Tax Amount, after tax, of expense for award under share-based payment arrangement. View
us-gaap Amortization of Intangible Assets The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Cash Equivalents, at Carrying Value Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Outstanding Number of warrants or rights outstanding. View
us-gaap Common Stock, Capital Shares Reserved for Future Issuance Aggregate number of common shares reserved for future issuance. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Amount of subscription receivable from investors who have been allocated common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Subscriptions Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Conversion of Stock, Shares Issued "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Convertible Notes Payable, Noncurrent Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. View
us-gaap Convertible Notes Payable Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. View
us-gaap Convertible Notes Payable, Current Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. View
us-gaap Debt Instrument, Annual Principal Payment Amount of the total principal payments made during the annual reporting period. View
us-gaap Debt Instrument, Convertible, Conversion Price The price per share of the conversion feature embedded in the debt instrument. View
us-gaap Deferred Tax Assets, Capital Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Deposit Assets The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement. View
us-gaap Deposit Contracts, Liabilities Carrying amount of liabilities as of the balance sheet date pertaining to amounts received by the insurer or reinsurer from the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred. View
us-gaap Deposit Liability, Current The current portion, due within one year or one operating cycle, if longer, of deposits held other than customer deposits. View
us-gaap Deposits Assets Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future. View
us-gaap Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. View
us-gaap Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) Cumulative net losses reported during the development stage. View
us-gaap Dividends Receivable Carrying amount as of the balance sheet date of dividends declared but not received. View
us-gaap Due to Related Parties, Current Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) Amount per share or per unit assigned to the consideration received of equity securities issued for development stage entities. View
us-gaap Extinguishment of Debt, Amount Gross amount of debt extinguished. View
us-gaap Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability. View
us-gaap Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price). View
us-gaap Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. View
us-gaap Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) Risk-free interest rate assumption used in valuing an instrument. View
us-gaap Finite-Lived Intangible Assets, Accumulated Amortization Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. View
us-gaap Finite-Lived Intangible Assets, Gross Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. View
us-gaap Finite-Lived Intangible Assets, Net Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. View
us-gaap Gain (Loss) Related to Litigation Settlement Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. View
us-gaap Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. View
us-gaap Gains (Losses) on Restructuring of Debt For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete. View
us-gaap General Contractor Costs (Deprecated 2018-01-31) The aggregate costs related to general contracting services. View
us-gaap Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Income Taxes Paid The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss. View
us-gaap Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit). View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. View
us-gaap Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. View
us-gaap Increase (Decrease) in Accounts Payable, Trade Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. View
us-gaap Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. View
us-gaap Increase (Decrease) in Accrued Interest Receivable, Net The increase (decrease) during the reporting period in the amount due from borrowers for interest payments. View
us-gaap Increase (Decrease) in Interest Payable, Net The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Expense, Short-term Borrowings The aggregate interest expense incurred on short-term borrowings including commercial paper and Federal funds purchased and securities sold under agreements to repurchase. View
us-gaap Interest Paid, Including Capitalized Interest, Operating and Investing Activities Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. View
us-gaap Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap License Costs (Deprecated 2018-01-31) Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Other Income Amount of revenue and income classified as other. View
us-gaap Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other. View
us-gaap Other Prepaid Expense, Current Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Payments to Acquire Intangible Assets The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. View
us-gaap Payments to Acquire Machinery and Equipment The cash outflow for acquisition of machinery and equipment. View
us-gaap Payments to Acquire Other Productive Assets Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. View
us-gaap Proceeds from Convertible Debt The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Issuance of Private Placement The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. View
us-gaap Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation. View
us-gaap Proceeds from (Repayments of) Debt The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings. View
us-gaap Proceeds from (Repayments of) Other Debt Amount of cash inflow (outflow) for debt classified as other. View
us-gaap Proceeds from (Repayments of) Other Long-term Debt Amount of cash inflow (outflow) from other long-term debt. View
us-gaap Proceeds from Sale of Other Assets Amount of cash inflow from the sale of other assets as part of operating activities. View
us-gaap Proceeds from Short-term Debt The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Proceeds from Stock Plans The cash inflow associated with the amount received from the stock plan during the period. View
us-gaap Professional Fees A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Related Party Transaction, Amounts of Transaction Amount of transactions with related party during the financial reporting period. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted Net number of non-option equity instruments granted to participants. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Number of equity instruments other than options outstanding, including both vested and non-vested instruments. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Net number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Payment Arrangement, Plan Modification, Incremental Cost An excess of the fair value of the modified award over the fair value of the award immediately before the modification. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Weighted average grant-date fair value of non-vested options outstanding. View
us-gaap Share Price Price of a single share of a number of saleable stocks of a company. View
us-gaap Shares, Issued Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. View
us-gaap Shares Issued, Price Per Share Per share or per unit amount of equity securities issued. View
us-gaap Short-term Bank Loans and Notes Payable Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer. View
us-gaap Short-term Debt Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. View
us-gaap Short-term Non-bank Loans and Notes Payable Amount of borrowings from a creditor other than a bank with a maturity within one year or operating cycle, if longer. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) This item represents the conversion ratio used in the calculation of a stock split. View
us-gaap Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities. View
us-gaap Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration (Deprecated 2015-01-31) Number of shares issued for noncash consideration for development stage entities. View
us-gaap Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Other Value of shares of stock issued attributable to transactions classified as other. View
us-gaap Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective. View
us-gaap Unsecured Debt, Current Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Income Taxes Paid, Net The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes. View
us-gaap Increase (Decrease) in Prepaid Expenses, Other Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. View
us-gaap Payments for Repurchase of Warrants The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Related Party Deposit Liabilities Amount of deposits held by the entity for a related party (entity, shareholder, employee). View
us-gaap Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Proceeds from Other Equity Amount of cash inflow from the issuance of equity classified as other. View
Chart of Accounts => Accounts
Name View
Convertible Notes Payable, Noncurrent View
Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) View
Other Nonoperating Income (Expense) View
Proceeds from (Repayments of) Other Long-term Debt View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture View
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period View
Stock Issued During Period, Shares, Other View
Operating Expenses View
Operating Income (Loss) View
Operating Loss Carryforwards View
Other Income View
Accounts Payable and Accrued Liabilities, Current View
Accounts Payable and Other Accrued Liabilities View
Accounts Payable, Current View
Accounts Receivable, after Allowance for Credit Loss, Current View
Accretion Expense View
Accrued Liabilities, Current View
Additional Paid in Capital View
Amortization View
Advances to Affiliate View
Share-based Payment Arrangement, Expense View
Share-based Payment Arrangement, Expense, after Tax View
Amortization of Intangible Assets View
Assets View
Assets, Current View
Cash View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Fair Value Disclosure View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect View
Cash Equivalents, at Carrying Value View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Class of Warrant or Right, Outstanding View
Common Stock, Capital Shares Reserved for Future Issuance View
Common Stock, Par or Stated Value Per Share View
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Subscriptions View
Common Stock, Value, Issued View
Conversion of Stock, Shares Issued View
Convertible Notes Payable View
Convertible Notes Payable, Current View
Debt Instrument, Annual Principal Payment View
Debt Instrument, Convertible, Conversion Price View
Deferred Tax Assets, Capital Loss Carryforwards View
Deferred Tax Assets, Gross View
Deferred Tax Assets, Net of Valuation Allowance View
Deferred Tax Assets, Operating Loss Carryforwards, Domestic View
Deferred Tax Assets, Valuation Allowance View
Deposit Assets View
Deposit Contracts, Liabilities View
Deposit Liability, Current View
Deposits Assets View
Depreciation View
Dividends Receivable View
Due to Related Parties, Current View
Earnings Per Share, Basic and Diluted View
Earnings Per Share, Diluted View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) View
Extinguishment of Debt, Amount View
Fair Value Adjustment of Warrants View
Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) View
Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) View
Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) View
Finite-Lived Intangible Assets, Accumulated Amortization View
Finite-Lived Intangible Assets, Gross View
Finite-Lived Intangible Assets, Net View
Gain (Loss) Related to Litigation Settlement View
Gain (Loss) on Extinguishment of Debt View
Gains (Losses) on Restructuring of Debt View
General and Administrative Expense View
General Contractor Costs (Deprecated 2018-01-31) View
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest View
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest View
Income Tax Expense (Benefit) View
Income Taxes Paid View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount View
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount View
Effective Income Tax Rate Reconciliation, Tax Credit, Amount View
Increase (Decrease) in Accounts Payable and Accrued Liabilities View
Increase (Decrease) in Accounts Payable, Trade View
Increase (Decrease) in Accounts Receivable View
Increase (Decrease) in Accrued Interest Receivable, Net View
Increase (Decrease) in Interest Payable, Net View
Increase (Decrease) in Prepaid Expense View
Interest Expense View
Interest Expense, Short-term Borrowings View
Interest Paid, Including Capitalized Interest, Operating and Investing Activities View
Interest Paid, Excluding Capitalized Interest, Operating Activities View
Issuance of Stock and Warrants for Services or Claims View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
License Costs (Deprecated 2018-01-31) View
Long-term Line of Credit View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Investing Activities View
Net Cash Provided by (Used in) Operating Activities View
Net Income (Loss) Attributable to Parent View
Nonoperating Income (Expense) View
Other Prepaid Expense, Current View
Payments to Acquire Intangible Assets View
Payments to Acquire Machinery and Equipment View
Payments to Acquire Other Productive Assets View
Prepaid Expense, Current View
Prepaid Expense View
Proceeds from Convertible Debt View
Proceeds from Deposits on Real Estate Sales View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Private Placement View
Proceeds from Notes Payable View
Proceeds from (Repayments of) Debt View
Proceeds from (Repayments of) Other Debt View
Proceeds from Sale of Other Assets View
Proceeds from Short-term Debt View
Proceeds from Stock Options Exercised View
Proceeds from Stock Plans View
Professional Fees View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Related Party Transaction, Amounts of Transaction View
Research and Development Expense View
Retained Earnings (Accumulated Deficit) View
Revenues View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted View
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value View
Share-based Payment Arrangement, Plan Modification, Incremental Cost View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price View
Share Price View
Shares, Issued View
Shares Issued, Price Per Share View
Short-term Bank Loans and Notes Payable View
Short-term Debt View
Short-term Non-bank Loans and Notes Payable View
Stockholders' Equity Attributable to Parent View
Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) View
Stock Issued During Period, Shares, Conversion of Convertible Securities View
Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration (Deprecated 2015-01-31) View
Stock Issued During Period, Shares, Issued for Services View
Stock Issued During Period, Shares, New Issues View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Stock Issued During Period, Value, Issued for Services View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Other View
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture View
Temporary Equity, Share Subscriptions View
Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax View
Unsecured Debt, Current View
Weighted Average Number of Shares Outstanding, Diluted View
Income Taxes Paid, Net View
Increase (Decrease) in Prepaid Expenses, Other View
Payments for Repurchase of Warrants View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Related Party Deposit Liabilities View
Net Income (Loss) Available to Common Stockholders, Basic View
Earnings Per Share, Basic View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Weighted Average Number of Shares Outstanding, Basic View
Proceeds from Other Equity View